| 摘要 |
The present invention provides a method for detecting the risk of Alzheimer's disease, comprising detecting immunomagnetic reduction signals of two biological markers in a biological sample from a subject, wherein the two biological markers is tau protein and A²-42 protein, respectively; and calculating concentrations of the above two biological markers and using the product of the concentrations of the above two biological markers to diagnosing the risk of Alzheimer's disease , wherein the concentration is calculated by the conversion of the magnetic reduction signals. |
